PAVmed Inc. - Common Stock (NQ:PAVM)

2.930 +0.270 (+10.15%)

Delayed Quote Updated: 10:46 AM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about PAVmed Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference

March 30, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2021 Financial Results

March 29, 2022

From PAVmed Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

January 18, 2022

Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a...

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

Earnings Preview: PAVmed ↗

March 28, 2022

PAVmed (NASDAQ:PAVM) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that PAVmed will report an...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study

March 24, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

March 23, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed Highlights First-In-Human Implantations of its PortIO Infusion System ↗

March 17, 2022

PAVmed Inc (NASDAQ: PAVM) announced the successful implantation of its PortIO Intraosseous Infusion System in three patients as part of a first-in-human (FIH)...

Via Benzinga

PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System

March 17, 2022

From PAVmed Inc.

Via Business Wire

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

PAVmed Appoints Shaun O’Neil as Chief Operating Officer

February 24, 2022

From PAVmed Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

February 15, 2022

From PAVmed Inc.

Via Business Wire

Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

February 10, 2022

From Lucid Diagnostics Inc.

Via Business Wire

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

January 12, 2022

From PAVmed Inc. and Lucid Diagnostics Inc.

Via Business Wire

Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

January 06, 2022

From Lucid Diagnostics Inc.

Via Business Wire

50 Biggest Movers From Yesterday ↗

December 23, 2021

Gainers Society Pass Incorporated (NASDAQ: SOPA) shares surged 53.4% to settle at $16.31 on Wednesday. Acasti Pharma Inc. (NASDAQ: ACST) jumped 52.3% to close at $1.69 on...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 22, 2021

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

December 22, 2021

Gainers Red Cat Holdings, Inc. (NASDAQ: RCAT) shares surged 31.7% to $2.41 after the company announced it was awarded a multiple award blanket purchase agreement by the United...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 22, 2021

Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $...

Via Benzinga

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

December 01, 2021

From Lucid Diagnostics Inc.

Via Business Wire

61 Biggest Movers From Yesterday ↗

November 18, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped...

Via Benzinga

Topics Initial Public Offering

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 17, 2021

Gainers EyePoint Pharmaceuticals (NASDAQ:EYP...

Via Benzinga

42 Stocks Moving In Wednesday's Mid-Day Session ↗

November 17, 2021

Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed...

Via Benzinga

Topics Initial Public Offering

Mid-Morning Market Update: Markets Down; Lowe's Earnings Beat Estimates ↗

November 17, 2021

Following the market opening Wednesday, the Dow traded down 0.34% to 36,017.63 while the NASDAQ fell 0.19% to 15,944.13. The S&P also fell, dropping 0.23% to 4,690.06. The U.S...

Via Benzinga

Topics Earnings Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 17, 2021

Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The...

Via Benzinga

Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

November 17, 2021

From Lucid Diagnostics Inc. PAVmed Inc.

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 17, 2021

Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.